Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PA

WKN: A42KRS | ISIN: KYG5880S1396 | Ticker:
NASDAQ
18.11.26 | 17:29
1,490 US-Dollar
+5,67 % +0,080
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
PING AN BIOMEDICAL CO LTD Chart 1 Jahr
5-Tage-Chart
PING AN BIOMEDICAL CO LTD 5-Tage-Chart

Aktuelle News zur PING AN BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
PING AN BIOMEDICAL Aktie jetzt für 0€ handeln
DiPing An Biomedical Co., Ltd. - 6-K, Report of foreign issuer-
04.11.Ping An Biomedical Co., Ltd: Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell Technologies2
30.10.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer2
22.10.Ping An Biomedical plans patent acquisition for $2-2.5M1
22.10.Ping An Biomedical plant Erwerb von Medizintechnik-Patenten für 2 bis 2,5 Millionen US-Dollar1
22.10.Ping An Biomedical Co., Ltd: Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio1
21.10.Ping An Biomedical Co., Ltd: Ping An Biomedical Announces 1-for-40 Reverse Stock Split1
21.10.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer1
11.09.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer1
07.08.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer2
22.07.Ping An Biomedical signs distribution deal with health services firm1
22.07.Ping An Biomedical Co., Ltd: Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years279HONG KONG, July 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (hereinafter referred to as "Ping An Biomedical") announced that it has formally signed a strategic cooperation...
► Artikel lesen
20.07.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer1
27.05.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer2
19.03.Ping An Biomedical Co., Ltd: All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital318HONG KONG, March 19, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that shareholders have approved all five resolutions at...
► Artikel lesen
09.01.Ping An Biomedical Co., Ltd.: Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry861HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that it has entered into a non-binding memorandum (the...
► Artikel lesen
09.01.Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation447HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") today announced that it has entered into a series of share purchase...
► Artikel lesen
28.11.25Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter291Hong Kong, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the "Company") today announced receipt of Nasdaq Minimum Bid Price Deficiency Letter. On November 24, 2025...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1